A study of Ferriprox to see how safe it is and how well it works

• Research type

  Research Study

• Full title

  The efficacy and safety of Ferriprox® for the treatment of transfusional iron overload in patients with sickle cell disease or other anaemias

• IRAS ID

  135912

• Contact name

  Baba Inusa

• Contact email

  baba.inusa@gstt.nhs.uk

• Sponsor organisation

  ApoPharma Inc.

• Eudract number

  2013-002181-39

• ISRCTN Number

  n/a

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  13/LO/1323

• Date of REC Opinion

  28 Oct 2013

• REC opinion

  Further Information Favourable Opinion